All stock lists
Cal-Maine Foods, Inc. (NASDAQ:CALM)
US · Delayed Price · Currency is USD
Consumer Defensive · Agricultural Farm Products
$64.18-$2.53 (-3.79%)
Market cap
$3.00B
Insider Score
Health Score
Analyst consensus
Listed since
Dec 12, 1996
Website
Insider Score
––Not scored
CALM Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Strong
From CALM’s reported statements · Q3 2026 (trailing 12 months)
Profitability11 / 20
Profitable, but on a thin margin.
- Revenue
- $2.53B
- Net income
- $58.7M
- Net margin
- 2.3%
Leverage20 / 20
Little or no net debt.
- Total debt
- $0
- Cash
- $113.5M
- Net debt / EBITDA
- -0.78x
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $1.47B
- Current liabilities
- $191.1M
- Current ratio
- 7.70
Cash generation11 / 20
Roughly cash-neutral.
- Operating cash flow
- $103.0M
- Free cash flow
- -$29.5M
- FCF margin
- -1.2%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 46.7M
- Share growth (1y)
- -3.5%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
CALM Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Aug 29, 2026 | May 30, 2026 | Feb 28, 2026 | Nov 29, 2025 | Aug 30, 2025 | May 31, 2025 |
| Revenue | $539.61 M | $552.58 M | $666.95 M | $769.50 M | $922.60 M | $1.10 B |
| Revenue Growth (YoY) | -41.51 % | -49.93 % | -52.95 % | -19.40 % | 17.40 % | 72.23 % |
| Cost of Revenue | $539.20 M | $518.51 M | $547.67 M | $562.11 M | $611.29 M | $572.15 M |
| Gross Profit | $403.00 K | $34.07 M | $119.28 M | $207.39 M | $311.31 M | $531.51 M |
| SG&A Expense | $84.15 M | $93.59 M | $83.30 M | $82.89 M | $69.51 M | $94.92 M |
| R&D Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $84.15 M | $92.88 M | $83.34 M | $83.52 M | $62.13 M | $95.66 M |
| Operating Income | -$83.75 M | -$58.81 M | $35.94 M | $123.87 M | $249.18 M | $435.85 M |
| Pretax Income | -$74.20 M | -$46.53 M | $58.19 M | $136.08 M | $263.26 M | $453.20 M |
| Tax Provision | -$17.99 M | -$11.49 M | $7.07 M | $33.15 M | $64.16 M | $111.07 M |
| Net Income | -$58.62 M | -$35.88 M | $50.46 M | $102.76 M | $199.34 M | $342.48 M |
| EPS (Basic) | -$1.26 | -$0.76 | $1.07 | $2.14 | $4.13 | $7.05 |
| EPS (Diluted) | -$1.26 | -$0.76 | $1.06 | $2.13 | $4.12 | $7.04 |
| Shares Outstanding | 46.70 M | 47.00 M | 47.30 M | 48.02 M | 48.38 M | 48.55 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.